Fairvalue-Calculator Fairvalue-Calculator
EN DE

S.M.A.I.O S.A (ALSMA) Fair Value & Analysis

Healthcare · FR · Market cap €54.6M

Price€7.56
Fair Value€4.39
Upside-41.9%
Quality95/100
Evidence: Low Range €3.30 – €5.49

Fair value as of: Jun 24, 2026

Analysis

S.M.A.I.O S.A (ALSMA) currently trades at €7.56, while our model-based Fair Value estimate is €4.39 — implying the stock looks roughly 41.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. It offers solutions for surgeons including programs for training, assistance with surgical planning based on a database called KEOPS. The company also offers solutions such as i-PLAN, take control of the realignment plan; i-PERFORM, take control of the surgical plan; i-CHECK, take control of the outcome data; and i-LEARN, take control of the education. S.M.A.I.O S.A. was incorporated in 2009 and is based in Saint-Priest, France.

Open the full interactive analysis →

Similar stocks

Veeva Systems Inc (VEEV) +20% Pro Medicus Limited (PME) -81% BrightSpring Health Services, Inc (BTSG) -61% Tempus AI, Inc (TEM) -74% HealthEquity, Inc (HQY) -6% M3, Inc (MTHRY) +43%

Frequently asked questions

Is S.M.A.I.O S.A (ALSMA) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €4.39 versus a price of €7.56 — about −42% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ALSMA?
Our 21-model fair value for S.M.A.I.O S.A is €4.39 (as of Jun 24, 2026), built from audited fundamentals. The current price is €7.56.
What is the quality score of ALSMA?
S.M.A.I.O S.A has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.